Claiborne Cary J
SEC CIK 1370930 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ADIL | ADIAL PHARMACEUTICALS, INC. | CEO, Dir | 40.4K | — | — | 4 | 2022-08-18 | 2026-04-07 |
Most active insiders at ADIL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Coastlands Capital LP | 10% | $106.3K | — |
| 2 | Shah Vinay | CFO | — | — |
| 3 | Davidson Matt | Chief Development Off, Dir | — | — |
| 4 | Gilliland Robertson H. | Dir | — | — |
| 5 | Schuyler Kevin | Dir | — | — |
| 6 | Goodman Tony | COO, Dir | — | — |
| 7 | Claiborne Cary J | CEO, Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-09 17:00 | 2026-04-07 | ADIL | ADIAL PHARMACEUTICALS, INC. | Claiborne Cary J | CEO, Dir | A - Grant | $0.00 | +38.0K | 40.4K | +1,562% | $0 | |
| D | 2023-05-25 | 2023-05-23 | ADIL | ADIAL PHARMACEUTICALS, INC. | Claiborne Cary J | CEO, Dir | A - Grant | $0.00 | +420.0K | 1.52M | +38% | $0 |
| M | 2022-09-20 | 2022-09-19+ | ADIL | ADIAL PHARMACEUTICALS, INC. | Claiborne Cary J | CEO, Dir | A - Grant | $0.4225 | +100.0K | 1.02M | +11% | +$42.2K |
| 2022-08-22 | 2022-08-18 | ADIL | ADIAL PHARMACEUTICALS, INC. | Claiborne Cary J | CEO | A - Grant | $0.00 | +1.00M | 1.00M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations